127 related articles for article (PubMed ID: 29750943)
1. Metabolomics analysis of the potential anticancer mechanism of annonaceous acetogenins on a multidrug resistant mammary adenocarcinoma cell.
Ma C; Li Y; Wu H; Ji J; Sun Q; Song Y; Wang S; Li X; Chen Y; Chen J
Anal Biochem; 2018 Jul; 553():1-6. PubMed ID: 29750943
[TBL] [Abstract][Full Text] [Related]
2. Non-targeted metabolomic analysis on multidrug resistance hepatocellular carcinoma cell and reversal effect of annonaceous acetogenins.
Ma C; Yan X; Yin G; Wang Y; Hu S; Xia W; Chen Y; Liu X; Chen J; Li X
J Pharm Biomed Anal; 2019 Feb; 164():489-495. PubMed ID: 30448539
[TBL] [Abstract][Full Text] [Related]
3. [Structure-activity relationship of annonaceous acetogenins against multidrug resistant human hepatic carcinoma cell line SMMC-7721/ADR].
Wang XN; Li X; Chen Y; Li Y
Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2518-2523. PubMed ID: 28840693
[TBL] [Abstract][Full Text] [Related]
4. [Structure activity relationship of annonaceous acetogenins against multidrug resistant human lung cancer cell line A549/Taxol in vitro].
Shi YY; Miao YJ; Chen YY; Ma CY; Chen Y; Chen JW; Li X
Zhongguo Zhong Yao Za Zhi; 2016 May; 41(10):1884-1888. PubMed ID: 28895338
[TBL] [Abstract][Full Text] [Related]
5. Annonaceous acetogenins mediated up-regulation of Notch2 exerts growth inhibition in human gastric cancer cells in vitro.
Li Y; Ye J; Chen Z; Wen J; Li F; Su P; Lin Y; Hu B; Wu D; Ning L; Xue Q; Gu H; Ning Y
Oncotarget; 2017 Mar; 8(13):21140-21152. PubMed ID: 28416750
[TBL] [Abstract][Full Text] [Related]
6. Folate-targeting annonaceous acetogenins nanosuspensions: significantly enhanced antitumor efficacy in HeLa tumor-bearing mice.
Li H; Li Y; Ao H; Bi D; Han M; Guo Y; Wang X
Drug Deliv; 2018 Nov; 25(1):880-887. PubMed ID: 29608108
[TBL] [Abstract][Full Text] [Related]
7. Annonaceous acetogenins (ACGs) nanosuspensions based on a self-assembly stabilizer and the significantly improved anti-tumor efficacy.
Hong J; Li Y; Xiao Y; Li Y; Guo Y; Kuang H; Wang X
Colloids Surf B Biointerfaces; 2016 Sep; 145():319-327. PubMed ID: 27209384
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of diverse ACGs against multidrug resistant human lung cancer cell line A549/Taxol.
Yuan F; Bai G; Chen Y; Miao Y; Chen J; Li X
Bioorg Med Chem Lett; 2015 Feb; 25(4):787-90. PubMed ID: 25582602
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of diverse Annonaceous acetogenins against multidrug resistant human mammary adenocarcinoma (MCF-7/Adr) cells.
Oberlies NH; Chang CJ; McLaughlin JL
J Med Chem; 1997 Jun; 40(13):2102-6. PubMed ID: 9207950
[TBL] [Abstract][Full Text] [Related]
10. Folate-modified Annonaceous acetogenins nanosuspensions and their improved antitumor efficacy.
Hong J; Sun Z; Li Y; Guo Y; Liao Y; Liu M; Wang X
Int J Nanomedicine; 2017; 12():5053-5067. PubMed ID: 28765708
[TBL] [Abstract][Full Text] [Related]
11. Investigations on the cell metabolomics basis of multidrug resistance from tumor cells by ultra-performance liquid chromatography-mass spectrometry.
Zhang R; Zhuang X; Zong L; Liu S; Liu Z; Song F
Anal Bioanal Chem; 2016 Aug; 408(21):5843-5854. PubMed ID: 27379392
[TBL] [Abstract][Full Text] [Related]
12. Annonaceous acetogenins nanosuspensions stabilized by PCL-PEG block polymer: significantly improved antitumor efficacy.
Hong J; Li Y; Li Y; Xiao Y; Kuang H; Wang X
Int J Nanomedicine; 2016; 11():3239-53. PubMed ID: 27486323
[TBL] [Abstract][Full Text] [Related]
13. Three new antitumor annonaceous acetogenins from the seeds of Annona squamosa.
Ma C; Wang Q; Shi Y; Li Y; Wang X; Li X; Chen Y; Chen J
Nat Prod Res; 2017 Sep; 31(18):2085-2090. PubMed ID: 28064519
[TBL] [Abstract][Full Text] [Related]
14. Acetogenins as Potential Anticancer Agents.
Mangal M; Khan MI; Agarwal SM
Anticancer Agents Med Chem; 2015; 16(2):138-59. PubMed ID: 26118710
[TBL] [Abstract][Full Text] [Related]
15. Sensitive Tumor Cell Line for Annonaceous Acetogenins and High Therapeutic Efficacy at a Low Dose for Choriocarcinoma Therapy.
Ao H; Li HW; Lu LK; Fu JX; Han MH; Guo YF; Wang XT
J Biomed Nanotechnol; 2021 Oct; 17(10):2062-2070. PubMed ID: 34706806
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of annonaceous acetogenins in HepS and S180 xenografts bearing mice.
Chen Y; Chen JW; Xu SS; Wang Y; Li X; Cai BC; Fan NB
Bioorg Med Chem Lett; 2012 Apr; 22(8):2717-9. PubMed ID: 22446092
[TBL] [Abstract][Full Text] [Related]
17. Annonaceous acetogenins reverses drug resistance of human hepatocellular carcinoma BEL-7402/5-FU and HepG2/ADM cell lines.
Qian JQ; Sun P; Pan ZY; Fang ZZ
Int J Clin Exp Pathol; 2015; 8(9):11934-44. PubMed ID: 26617951
[TBL] [Abstract][Full Text] [Related]
18. Enhanced anti-glioma activity of annonaceous acetogenins based on a novel liposomal co-delivery system with ginsenoside Rh2.
Ao H; Song H; Li J; Wang X
Drug Deliv; 2024 Dec; 31(1):2324716. PubMed ID: 38555735
[TBL] [Abstract][Full Text] [Related]
19. The Annonaceous acetogenin bullatacin is cytotoxic against multidrug-resistant human mammary adenocarcinoma cells.
Oberlies NH; Croy VL; Harrison ML; McLaughlin JL
Cancer Lett; 1997 May; 115(1):73-9. PubMed ID: 9097981
[TBL] [Abstract][Full Text] [Related]
20. Untargeted metabolomics study and pro-apoptotic properties of B-norcholesteryl benzimidazole compounds in ovarian cancer SKOV3 cells.
Gan C; Huang X; Wu Y; Zhan J; Zhang X; Liu Q; Huang Y
J Steroid Biochem Mol Biol; 2020 Sep; 202():105709. PubMed ID: 32535031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
